N. Tarashima et al. / Bioorg. Med. Chem. 20 (2012) 7095–7100
7099
(MNa+); ESIMS-HR Calcd for C13H13ClN6O3Na 359.0635, found
359.0660.
(704 mg, 78%) as a white solid: 1H NMR (DMSO-d6) d 11.46 (s,
1H, exchangeable with D2O), 9.97 and 8.87 (each s, each 1H),
7.92 and 7.73 (each d, each 2H, J = 8.3 Hz), 7.11–6.58 (m, 13 H),
6.56 (m, 1 H), 5.50 (d, 1H, J = 5.8 Hz, exchangeable with D2O),
4.54 (m, 1H), 4.08 (m, 1H), 3.65 (s, 6H), 3.25 (m, 1H), 3.13 (dd,
1H, J = 2.5, 10.6 Hz), 2.78 (dd, 1H, J = 4.7, 10.6 Hz), 2.63 (m, 1H);
13C NMR (DMSO-d6) d 165.31, 158.48, 157.84, 157.81, 157.48,
156.18, 152.88, 144.50, 141.95, 135.28, 135.20, 133.89, 132.71,
132.31, 131.50, 130.61, 129.32, 129.27, 129.18, 127.56, 127.50,
127.31, 126.45, 112.83, 108.52, 85.80, 85.25, 84.92, 79.15, 68.90,
62.06, 54.89, 37.88; ESIMS-LR m/z = 844 (MNa+); ESIMS-HR Calcd
for C41H34BrClN6O6 843.1278, found 843.1309.
3.3. N4-p-Bromobenzoylamino-7-chloro-1-(2-deoxy-3,5-di-O-
triisopropylsilyl-b-
d]pyrimidine (6)
D
-ribofuranosyl)imidazo[50,40:4,5]pyrido[2,3-
To a solution of 1 (1.07 g, 1.6 mmol) in CH2Cl2 (16 mL) including
N,N-diisopropylethylamine (1.66 mL, 9.8 mmol) was added p-
BrBzCl (1.07 g, 4.9 mmol), and the reaction mixture was stirred
for 12 h at room temperature. The reaction was quenched by addi-
tion of ice and the reaction mixture was partitioned between CHCl3
and H2O. The separated organic layer was washed with saturated
aqueous NaHCO3 and brine. The organic layer was dried (Na2SO4)
and concentrated in vacuo. Then, the residue was dissolved in a
mixture of EtOH–THF (32 mL each) and NaOEt (2.66 mL of 20%
EtOH solution) was added at 0 °C. After being stirred for 10 min,
the reaction mixture was neutralized by 1 N HCl. The solvent
was removed in vacuo, and the residue was partitioned between
CHCl3 and H2O. The separated organic layer was washed with sat-
urated aqueous NaHCO3 and brine. The organic layer was dried
(Na2SO4) and concentrated in vacuo, and the residue was purified
by a silica gel column (neutralized), eluted with MeOH in CHCl3
(0–5%), to give 6 (1.07 g, 80%) as a white solid: 1H NMR (DMSO-
d6) d 11.45 (s, 1H, exchangeable with D2O), 9.77 and 8.70 (each s,
each 1H), 7.98 and 7.77 (each d, each 2H, J = 8.5 Hz), 6.87 (dd,
1H, J = 5.3 Hz), 4.76 (m, 1H), 4.09 (m, 1H), 3.78 (dd, 1H, J = 3.8,
11.4 Hz), 3.65 (dd, 1H, J = 3.9, 11.4 Hz), 3.15 (m, 1H), 2.69 (ddd,
1H, J = 5.9, 13.3 Hz), 1.12–0.97 (m, 42H); 13C NMR (DMSO-d6) d
165.19, 158.08, 157.35, 156.07, 152.86, 141.65, 133.83, 132.68,
132.37, 131.55, 130.62, 126.47, 108.53, 87.87, 85.56, 70.71, 62.07,
17.83, 17.51, 11.56, 11.16; ESIMS-LR m/z = 853 (MNa+); ESIMS-HR
Calcd for C38H56BrClN6O4Si2Na 853.2671, found 853.2660.
Physical data for N4-p-Bromobenzoylamino-7-pyridiniumimi-
dazo[50,40:4,5]pyrido[2,3-d]pyrimidine chiloride (10): 1H NMR
(DMSO-d6) d 12.16 (br s, 1H, exchangeable with D2O), 10.28 and
8.78 (each s, each 1H), 10.18 (d, 2H, J = 5.7 Hz), 8.96 (t, 1H,
J = 7.5 Hz), 8.45 (m, 2 H), 8.10 and 8.82 (each d, each 2H).
3.6. N4-p-Bromobenzoylamino-7-chloro-1-[2-deoxy-5-O-(4,40-
dimethoxytrityl)-b-D
-ribofuranosyl]imidazo[50,40:4,5]pyrido-
[2,3-d]pyrimidine 2-cyanoethyl N,N0-diisopropylphospho-
ramidite (9)
To a mixture of 8 (205 mg, 0.25 mmol), N,N-diisopropylethyl-
amine (174
CH2Cl2 (5 mL) was added 2-cyanoethyl N,N-diisopropylchlorophos-
phoramidite (61 L, 0.28 mmol) at 0 °C. After the mixture was stir-
lL, 1.0 mmol), and dimethylaminopyridine (5 mg) in
l
red for 1 h at room temperature, the mixture was diluted with CHCl3.
The mixture was washed with saturated aqueous NaHCO3, followed
by brine. The separated organic layer was dried (Na2SO4), and con-
centrated in vacuo. The residue was purified by a silica gel column
(neutralized), eluted with hezane/AcOEt (4:1 to 1:2), to give 9
(148 mg, 58%) as a white foam: ESIMS-LR m/z 1044 (MNa+);
ESIMS-HR Calcd. for
C50H51BrClN8O7PNa 1045.2367, found
3.4. N4-p-Bromobenzoylamino-7-chloro-1-(2-deoxy-b-
D-
1045.2405; 31P NMR (CDCl3) d: 149.63, 149.07.
ribofuranosyl)imidazo[50,40:4,5]pyrido[2,3-d]pyrimidine (7)
3.7. Synthesis and characterization of ODNs containing ImNN
using the post-modification method
To a solution of 6 (400 mg, 0.48 mmol) in THF was added TBAF
(1 M in THF, 1.0 mL, 1 mmol) at 0 °C. After being stirred for 40 min
at room temperature, the the reaction was quenched by addition of
ODNs were synthesized on a DNA synthesizer (NTS H-6, Nihon
Techno Service) using the phosphoramidite unit 9, and commer-
cially available deoxyribonucoside phosphoramidite units (benzoyl
protected dA, acetyl protected dC, and isobutyryl protected dG) at
acetic acid (60 lL, 1.0 mmol). The solvent was removed in vacuo,
and the residue was purified by a silica gel column, eluted with
MeOH in CHCl3 (0–15%), to give 7 (250 mg, quant) as a white solid:
1H NMR (DMSO-d6) d 11.47 (br s, 1H, exchangeable with D2O), 9.75
and 8.82 (each s, each 1H), 7.99 and 7.77 (each d, each 2H,
J = 8.5 Hz), 6.80 (m, 1H), 5.46 (d, 1H, J = 5.0 Hz, exchangeable with
D2O), 4.88 (t, 1H, J = 5.2 Hz, exchangeable with D2O), 4.46 (m, 1H),
3.99 (m, 1H), 3.53 (ddd, 1 H, J = 4.3, 4.9, 11.8 Hz), 3.45 (m, 1 H), 2.90
(m, 1H), 2.58 (m, 1H); 13C NMR (DMSO-d6) d 157.34, 142.23,
131.55, 130.68, 126.46, 88.20, 85.98, 69.56, 60.66; ESIMS-LR m/
z = 540 (MH+); ESIMS-HR Calcd for C20H16BrClN6O4 541.0003,
found 540.9855.
0.2 lmol scale following the standard procedure. For the incorpo-
ration of 9 into the ODNs, a 0.11 M solution in dry CH3CN, and cou-
pling time of 10 min was used. After completion of synthesis, the
CPG support was then treated with concentrated NH4OH (2 mL)
at 55 °C for 17 h, and 0.2 M TEAA buffer (2 mL, pH 7.0) was added
to the reaction mixture. The whole mixture was pored onto a C-18
cartrige column (YMC dispoSPE, f 0.6 ꢀ 1.6 cm), and the column
was washed with 10% CH3CN in 0.1 M TEAA buffer (pH 7.0)
(2 mL), followed by H2O (3 mL). Then, a solution of 3% aq TFA
(4 mL) was eluted to remove the DMTr group. After being washed
with H2O (3 mL), 0.1 M TEAA buffer (2 mL), and H2O (3 mL), the
ODN was eluted with 20% and 50% aq CH3CN (3 mL each). An ali-
quot of eluate was analyzed by reverse-phase HPLC, using a
J’sphere ODN M80 column (4.6 ꢀ 150 mm, YMC) with linear gradi-
ent of acetonitrile (from 5 to 20% over 25 min) in 0.1 M TEAA buffer
(pH 7.0). The resulting ODN was further purified by reverse-phase
HPLC under the same conditions to give a highly purified ODNs.
The structure of ODNs containing ImNN were confirmed by MAL-
DI–TOF/MS: 50-GTGGGCAAGImNNGTGCGCTGACCATCCAGAAC-30,
calculated mass: C295H367N124O174P29 9331.0 (MHꢁ), observed
mass: 9336.2; 50-CGAAImNNAACC-30, calculated mass: C90H110N41
O47P8 2764.54 (MHꢁ), observed mass: 2766.52.
3.5. N4-p-Bromobenzoylamino-7-chloro-1-[2-deoxy-5-O-(4,40-
dimethoxytrityl)-b-
[2,3-d]pyrimidine (8)
D
-ribofuranosyl]imidazo[50,40:4,5]pyrido-
To a solution of 7 (571 mg, 1.1 mmol) in DMF (10 mL) contain-
ing triethylamine (0.91 mL, 6.6 mmol) was added DMTrCl (1.11 g,
3.3 mmol), and the reaction mixture was stirred for 22 h at room
temperuture. The reaction was quenched by addition of ice and
the reaction mixture was partitioned between CHCl3 and H2O.
The separated organic layer was washed with saturated aqueous
NaHCO3 and brine. The organic layer was dried (Na2SO4) and con-
centrated in vacuo, and the residue was purified by a silica gel col-
umn (neutralized), eluted with MeOH in CHCl3 (0–13%), to give 8